Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology ELISpot Platform: Unique Advantages of Leading Immune Response Analysis

Author:

InnoModels

Release time:

2024-06-25

Immune response analysis plays a pivotal role in the broad field of life science research. Especially in cancer immunotherapy, vaccine development and infectious disease research, accurate analysis of cytotoxic T-lymphocytes (CTLs) and their immune responses is crucial. With its advanced ELISpot platform, InnoModels Biotechnology provides researchers with a powerful and reliable experimental tool, and its unique advantages are well recognized in the industry.
1. High sensitivity detection capability
InnoModels' ELISpot platform stands out for its high sensitivity. This platform is capable of accurately detecting and quantitatively analyzing proteins released by individual cells, including cytokines, antibodies, etc., thus enabling quantitative and qualitative analysis of the level of CTLs produced. This advantage is particularly important in tumor vaccine research and cancer immunotherapy, as it enables accurate assessment of the activity of CTLs and thus the effectiveness of immunotherapy.
2、Specific MHC antigen delivery activates CTLs
In immune response analysis, specific activation of CTLs is the key to assessing the effect of immunotherapy. InnoModels' ELISpot platform utilizes the specific MHC antigen presentation pathway to activate CTLs, ensuring that the activation of CTLs is dependent on the presence of appropriate MHC molecules. This specific activation avoids activating CTLs in the presence of MHC mismatches, thereby improving the accuracy and reliability of the experiment.
3. Versatility and Flexibility
InnoModels' ELISpot platform is versatile and flexible to meet different research needs. The platform supports a variety of CTLs stimulation methods, including the use of human or mouse peripheral blood mononuclear cells (PBMCs) or splenic immune cells for in vitro specific antigen presentation, as well as the analysis of peripheral blood or splenic cells after in vivo immunization of immunologically sound mice. In addition, the platform also focuses on CTL detection in TILs, providing researchers with a broader research space.

4. Wide range of application areas
InnoModels' ELISpot platform has a wide range of applications in immunology research, biomedical research and vaccine development. The platform is not only suitable for clinical cancer vaccine research, but also for in vitro research of tumor vaccines and immunomodulatory drugs. Its high sensitivity and specificity give it a unique advantage in discovering new biomarkers and evaluating vaccine efficacy.
5、Customer training and technical support
As a company focusing on customer satisfaction, InnoModels Biotechnology not only provides advanced ELISpot technology, but is also committed to providing comprehensive training and technical support to users. Through online training, seminars and a professional technical support team, InnoModels Biotechnology ensures that users are able to fully understand and properly apply ELISpot technology to maximize its benefits.
6. Continuous Innovation and Development
InnoModels Biotechnology continues to invest in research and development in the field of ELISpot technology, launching new products and technological innovations. Close collaboration with academic and industrial partners keeps InnoModels Biotechnology at the forefront of technology and meets the constant demand for efficient and reliable immunoassay tools in the research field.
In summary, the ELISpot platform of InnoModels Biotechnology plays an irreplaceable role in life science research with its unique advantages of high sensitivity, specific MHC antigen presentation and activation of CTLs, versatility, flexibility, wide range of applications, as well as customer training and technical support. It is believed that in the future, the ELISpot platform of InnoModels Biotechnology will continue to provide powerful and reliable experimental tools for researchers and help them make more breakthroughs in the field of life sciences.

InnoModels Biotechnology ELISA Platform: Opening a New Era of Efficient and Accurate Biological Detection

InnoModels Biotechnology: iHuPDX Platform Features and Advantages

InnoModels Biotechnology ELISA Platform: Opening a New Era of Efficient and Accurate Biological Detection

InnoModels Biotechnology: iHuPDX Platform Features and Advantages

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License